SFA Therapeutics Employee Directory

SFA Therapeutics is focused on developing a next-generation oral immune tolerance therapy, SFA-002, for psoriasis, which aims to restore immune function without broadly suppressing the immune system. The investigational therapy is designed for once-daily dosing and has shown promising results in early human trials, demonstrating significant clearan... ce in plaque psoriasis. The company utilizes a proprietary deuteration platform to create new chemical entities from naturally occurring short-chain fatty acids, with plans to expand its pipeline to include treatments for pancreatic cancer, liver cancer, and other autoimmune diseases. SFA Therapeutics targets patients suffering from chronic inflammatory diseases, particularly those with mild to severe plaque psoriasis.Read More